SCHEMBL6590563

SCHEMBL6590563

COC(=O)c1ccc2cc(-c3oc(=O)c(C)c(OC(C)=O)c3C)oc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.41
CA9 Q16790 3/20 0.41
CREBBP Q92793 1/20 0.39
PSMB8 P28062 1/20 0.39
KDM4E B2RXH2 4/20 0.38
GLA P06280 3/20 0.38
GAA P10253 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
HSD17B10 Q99714 1/20 0.38
POLB P06746 3/20 0.38
HDAC6 Q9UBN7 3/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
TP53 P04637 1/20 0.37
THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6591799 0.91 POLB (0.46) CA12CA9CREBBPKDM4EALDH1A1
SCHEMBL6590541 0.84 ALDH1A1 (0.51) CA12CA9KDM4EGLAGAA
SCHEMBL6595537 0.84 CREBBP (0.42) CA12CA9CREBBPPSMB8KDM4E
SCHEMBL6594926 0.84 MIF (0.47) CA12CA9KDM4EGLAGAA
SCHEMBL6592169 0.84 KDM4E (0.53) CA12CA9KDM4EGLAGAA
SCHEMBL6595001 0.82 CD74 (0.49) CA12CA9KDM4EALDH1A1HPGD
SCHEMBL6593413 0.81 SLC16A3 (0.47) CA12CA9KDM4EGLAGAA
SCHEMBL6592783 0.80 KDM4E (0.41) CA12CA9KDM4EGLAGAA
SCHEMBL6591205 0.80 TP53 (0.42) CA12CA9KDM4EGAAALDH1A1
SCHEMBL6595025 0.79 MAOB (0.43) CA12CA9KDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1063235-B1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LTD (JP) 2004-05-12 EP disclosed
US-20030186976-A1 Benzofurylpyrone derivatives TEIJIN LIMITED, MICROBIAL CHEMISTRY RESEARCH FOUNDATION 2003-10-02 US disclosed
US-6589984-B1 Blood cholesterol and triglycerides (TG) themselves are generally insoluble in blood, and they exist as lipoproteins by binding with apolipoproteins. In the body, triglycerides are biosynthesized primarily in the liver from acetyl CoA as TEIJIN LIMITED (JP) 2003-07-08 US disclosed
EP-1063235-A1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LIMITED (JP) 2000-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186976-A1 Benzofurylpyrone derivatives PLIN5, ACSL5, PLIN1 CA12 4853/4885CA9 4589/4885CREBBP 741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.